February 10, 2017 / 12:37 PM / 6 months ago

BRIEF-Intercept Pharmaceuticals to update on trial of liver fibrosis treatment

Feb 10 (Reuters) - Intercept Pharmaceuticals Inc

* Intercept to provide update on phase 3 regenerate trial of obeticholic acid for the treatment of nash patients with liver fibrosis Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below